Summary: The cerebral venous system is an unusual site of thrombosis, with a particularly high incidence in young adults. This incidence has increased in past decades because of the improvement of neuroradiological techniques. Risk factors for cerebral venous sinus thrombosis overlap with those of other venous thromboembolism sites; however, some are specific for this particular anatomical district. Prognosis is favorable in most cases if diagnosis is made rapidly and treatment is promptly initiated, even if acute complications or chronic invalidity still occur in a quarter of patients. The mainstay of treatment is anticoagulation, which is necessary in order to block clot propagation and obtain recanalization. Intracranial bleeding does not contraindicate anticoagulation. Endovascular procedures are reserved for patients with a particularly severe presentation or rapidly declining neurological symptoms despite appropriate anticoagulation, although data from clinical trials are lacking. Specifically, this review addresses the epidemiology, clinical presentation and course, risk factors, and treatment of cerebral venous sinus thrombosis, with a special focus on the pediatric population.

Cerebral venous sinus thrombosis / M. Capecchi, M. Abbattista, I. Martinelli. - In: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. - ISSN 1538-7933. - 16:10(2018 Oct), pp. 1918-1931. [10.1111/jth.14210]

Cerebral venous sinus thrombosis

M. Capecchi
Primo
;
M. Abbattista
Secondo
;
2018

Abstract

Summary: The cerebral venous system is an unusual site of thrombosis, with a particularly high incidence in young adults. This incidence has increased in past decades because of the improvement of neuroradiological techniques. Risk factors for cerebral venous sinus thrombosis overlap with those of other venous thromboembolism sites; however, some are specific for this particular anatomical district. Prognosis is favorable in most cases if diagnosis is made rapidly and treatment is promptly initiated, even if acute complications or chronic invalidity still occur in a quarter of patients. The mainstay of treatment is anticoagulation, which is necessary in order to block clot propagation and obtain recanalization. Intracranial bleeding does not contraindicate anticoagulation. Endovascular procedures are reserved for patients with a particularly severe presentation or rapidly declining neurological symptoms despite appropriate anticoagulation, although data from clinical trials are lacking. Specifically, this review addresses the epidemiology, clinical presentation and course, risk factors, and treatment of cerebral venous sinus thrombosis, with a special focus on the pediatric population.
anticoagulants; cerebral hemorrhage; intracranial thrombosis; low-molecular-weight heparin; sinus thrombosis; venous thromboembolism; Adult; Age Factors; Animals; Anticoagulants; Blood Coagulation; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Male; Risk Factors; Sinus Thrombosis, Intracranial; Treatment Outcome; Endovascular Procedures
Settore MED/09 - Medicina Interna
ott-2018
Article (author)
File in questo prodotto:
File Dimensione Formato  
JTH review CVT.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 500.26 kB
Formato Adobe PDF
500.26 kB Adobe PDF Visualizza/Apri
jth.14210.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 487.98 kB
Formato Adobe PDF
487.98 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/812817
Citazioni
  • ???jsp.display-item.citation.pmc??? 71
  • Scopus 128
  • ???jsp.display-item.citation.isi??? 112
social impact